Inner ear gene therapy to prevent deafness in DFNA9. University of Antwerp
Laboratory for Experimental Hematology (LEH), Vaccine & Infectious Disease Institute (VAXINFECTIO), Translational Neurosciences (TNW)
Hearing loss has a significant impact on quality of life and society in general. Hearing impairment is the most frequent sensory deficit in human populations, affecting 360 million people worldwide. It was listed by the World Health Organization as one of the priority diseases for research into therapeutic interventions to address public health needs. DFNA9 is a dominant hereditary disorder, caused by heterozygote mutations in the COCH gene, ...